PMDA drug package insert
リオベル配合錠LD
PMDA Prescription drug · 帝人ファーマ株式会社 · package insert Mar 17, 2026
Key facts
| Brand names | リオベル配合錠LD, リオベル配合錠HD |
|---|---|
| Nonproprietary names | アログリプチン安息香酸塩・ピオグリタゾン塩酸塩配合剤 |
| Companies | 製造販売元／帝人ファーマ株式会社, 販売／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 選択的DPP-4阻害薬/チアゾリジン系薬配合剤; －2型糖尿病治療剤－ |
| Therapeutic category codes | 873969 |
| YJ codes | 3969103F1024, 3969103F2020 |
| Approval numbers | 22300AMX00590000, 22300AMX00589000 |
| Package insert edition | 第5版 |
| Package insert date | Mar 17, 2026 |
| PMDA document key | 470310_3969103F1024_2 |
| PMDA company code | 470310 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- 1–9 Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: